Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol and BRENDA for Cannabis Withdrawal
NCT00480441Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Aug 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cannabis use disorder (CUD) comparing Dronabinol + BRENDA with Placebo + BRENDA (2 arms). Primary endpoints: Physiological Changes in Response to Cue-induced Craving at Week 2 and Tolerability of Treatment at 7 weeks. Started Aug 2006; status: completed.
02
Drugs
dronabinol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00480441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00480441.